Kate is a UK and European patent attorney in our Chemical and Life Sciences department. She handles a wide variety of biotechnology and pharmaceutical subject matter, and has a particular interest in the areas of neuroscience and cardiology, in which she has a strong academic background. She also has considerable expertise in the fields of inhalation technology, drug delivery, cancer therapies, gene sequences, medical devices, cell culture technology, and diagnostic methods.
Kate has experience in all aspects of patent law, including drafting, filing and prosecuting UK, European and international patent applications, due diligence work, and involvement in opposition and appeal cases before the European Patent Office.
Kate works with clients varying in size and is able to provide clear and tailored advice to her clients to help them understand and maximize their IP.
Kate holds a first class degree in Biology from the University of York, which incorporated a 12-month placement with a pharmaceutical company. Her DPhil research at Oxford University involved the use of electrophysiology and immunocytochemistry. Kate subsequently held postdoctoral positions at the University of Queensland, Australia, during which she investigated developmental changes in neural stem cells, and the effect of ischaemia on cardiac ganglia; and with a biotechnology spin-out company from Oxford University. Kate holds a Certificate in Intellectual Property Law from Manchester University.
- Fellow of the Chartered Institute of Patent Attorneys
- Member of the European Patent Institute